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MYOCARD1A.L F9BROSIS IN THE TRANSPLANTED HEART: 
RELMIONTOTHEG~ ISCHEMICTIM& 
R. Boughner, MD, PhD. 
Impaired diastolic function has been demonslr$ed at on! year post 
transplantion. A possible relation lo myocardlal fibrosis _and ‘l?e 
original ischemic time has been suggested. To examme, thts 
possibility we developed and employed a computer-assisted 
videodensitometry technique to quantify myocardial coIla?% in 
endomyocardial biopsies. One hundred and ftiteen right ventncular 
(RV) endomyocaniial biopsies obtained 1 week post esplant (to 
avoid rejection and previous biopsy effects) in 36 patients were 
sectioned, stained with picrosirius red, and illuminated with 
monochromatic (600 5 5 nanometers), polarized light. This yie!d@ an 
image of bright collagen against a dark background that was dsgltlzed 
using the computer-video system. The percent collagen was 
determined from the area fraction of bright pixels. Twenty-three RV 
biopsies from age-matched autopsy hearts without cardiac pathology 
served as controls, 
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Collagen content was linearly related to allograft isch:mic rrme 
(r=O.60, pdM1) but not to donor age, cardiac output, right atrial 
pressun or wedge pressure. Thus changes in diastolic function were 
not detected at one week but increased fibrosis could already be 
identifledinthosealfograftssubjected toprolongedischemictimes. 
INHIBITION OF CARDIAC ALLOGRAFT ATHEROSCLEROSIS BY OE- 
HYDROEPIANDROSTERONE 
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Accelerated atherosclerosis (CAD) is a major cause of 
morbidity and mortality in cardiac transplantation. De- 
hydroepiandrosterone (DHEA) is an endogenously produced 
hormone which has been shown to decrease atherosclerosis 
in animals. IJe examined whether DHEA could inhibit CAD 
using outbred rabbits with heterotopically transplanted 
hearts. Accelerated atherosclerosis was produced by 
feeding these animals a 1% cholesterol diet. The animals 
were immunosuppressed with cyclosporine (5 mg/kg) and 
azathioprine (1 mg/kg), and they were randomly divided 
into 4 treatment groups: 1) low cholesterol diet, n=5; 
2) 1% cholesterol, n-5; 3) low cholesterol + 0.5% DHEA, 
n=5; 4) 1% cholesterol + 0.5% DHEA. The animals were 
sacrificed at 5 weeks, and the hearts were perfused at 
systemic pressure. The hearts were fixed in 10% formalin, 
the entire coronary arterial tree was cross sectioned and 
microscopic slides were prepared. Morphometry was per- 
formed 31) the arterial sections (n=840) and the percent 
cross sectional luminal area stenosis was calculated. The 
mean percent stenosis was 32% in Group 2 and 9% in Group 
4. Thus, the coronary arteries of the Group 4 animals 
showed a 72% decrease in luminal stenosis as compared to 
Group 2 (p.c.01). There was no sisnificant atheroscle- 
rosis in Groups 1 and 3. These data demonstrate that 
DHEA inhibits accelerated atherosclerosis in the rabbit 
heterotopic transplant mode?. 
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